Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2005
12/22/2005CA2569419A1 Double strand compositions comprising differentially modified strands for use in gene modulation
12/22/2005CA2569036A1 Chimeric gapped oligomeric compositions
12/22/2005CA2568735A1 Double strand compositions comprising differentially modified strands for use in gene modulation
12/22/2005CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005CA2567043A1 Biosynthetic gene cluster for the production of a complex polyketide
12/22/2005CA2566647A1 Inhibition of macrophage-stimulating protein receptor (ron)
12/22/2005CA2564784A1 Episomal fusion gene
12/22/2005CA2507844A1 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides
12/21/2005EP1606417A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
12/21/2005EP1606403A2 Hemipteran glutamate decarboxylase
12/21/2005EP1606305A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1606304A2 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
12/21/2005EP1606303A2 Detection and monitoring of lung cancer
12/21/2005EP1606302A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
12/21/2005EP1606301A2 Aptamer therapeutics useful in ocular pharmacotherapy
12/21/2005EP1605978A2 Therapeutic compositions
12/21/2005EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1605811A2 Expression profiles for breast cancer and methods of use
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1543156A4 Detection of chemical ligation using fluorescence quenching leaving groups
12/21/2005EP1534865A4 Methods and compositions for determining methylation profiles
12/21/2005EP1165815B1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1232528C Nucleic acid sequence, method and kit for diagnosis of meningitis pathogenic bacteria
12/21/2005CN1232343C Devices and methods for carrying out chemical reactions using photobiological reagents
12/20/2005US6977246 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
12/20/2005US6977245 Oligodeoxynucleotide and its use to induce an immune response
12/20/2005US6977178 System and method for transgenic and targeted mutagenesis screening
12/20/2005US6977170 Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
12/20/2005US6977164 Compositions and kits for Herpes Simplex Virus type 1 and 2 nucleic acid detection
12/20/2005US6977163 high throughput assay, biochemical analysis, genotyping; matrixed, microfluidic systems increase integration and automation
12/20/2005US6977162 Rapid analysis of variations in a genome
12/20/2005US6977151 Composition for use in forensic and diagnostic medicine
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/15/2005WO2005119255A2 Constrained cis-diol-borate bioconjugation system
12/15/2005WO2005119244A1 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
12/15/2005WO2005118882A2 Method for the taxon-specific identification of cells of gram-positive bacteria and devices for carrying out said method
12/15/2005WO2005118880A2 Novel dna synthesis technology with 3’-beaded oligo dna and dna polymerase
12/15/2005WO2005118874A1 Enhancing protein expression
12/15/2005WO2005118864A2 Antibodies and related molecules that bind to psca proteins
12/15/2005WO2005118859A2 Carrier tests for albinism in the cat
12/15/2005WO2005118857A2 Methods and agents for screening for compounds capable of modulating vegf expression
12/15/2005WO2005118855A1 Assay system using labeled oligonucleotides
12/15/2005WO2005118796A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
12/15/2005WO2005118629A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
12/15/2005WO2005118628A2 Nucleic acid molecules encoding plant cyclotide polypeptides and methods of use
12/15/2005WO2005118611A2 Microutrophin and uses thereof
12/15/2005WO2005117964A2 Cynomolgus prostate specific antigen
12/15/2005WO2005108610A3 Methods for the selection of subjects for multiple sclerosis therapy
12/15/2005WO2005098046A3 Methods for the determination of cell specific biomarkers
12/15/2005WO2005070966A3 Fusion polypeptides capable of activating receptors
12/15/2005WO2005046565A3 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases
12/15/2005WO2005046564A3 Diagnosis and treatment of liver fibrosis
12/15/2005WO2005044091A3 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
12/15/2005WO2005032328A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/15/2005WO2005023993A3 Methods and compositions for generation of germline human antibody genes
12/15/2005WO2005012359A3 Anti-vegf antibodies
12/15/2005WO2005005610A3 Mutant adeno-associated virus virions and methods of use thereof
12/15/2005WO2005001142A3 Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
12/15/2005WO2004101764A3 Methods of modulating metastasis and skeletal related events resulting from metastases
12/15/2005WO2004091526A3 Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies
12/15/2005WO2004064737A3 Therapeutics compositions
12/15/2005WO2004057015A3 Detecting a nucleic acid
12/15/2005WO2004053104A3 5’ cpg nucleic acids and methods of use
12/15/2005WO2004048511A3 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
12/15/2005WO2004012588A3 Use of biomarkers for detecting ovarian cancer
12/15/2005WO2004000102A3 Method for predicting response to epidermal growth factor receptor-directed therapy
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005US20050278809 Regulation of gene expression using chromatin remodelling factors
12/15/2005US20050278807 Plant raffinose saccharide biosynthetic enzymes
12/15/2005US20050278801 Plastid transit peptides
12/15/2005US20050278800 Compositions and methods for the modification of gene expression
12/15/2005US20050278796 FIAT nucleic acids and proteins and uses thereof
12/15/2005US20050278795 Stearoyl-CoA desaturase 4 gene
12/15/2005US20050277766 Udp-glucose aglycon-glucosytransferase
12/15/2005US20050277610 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277608 Prevent, inhibit, or reduce hair growth, for hair removal or depilation; alopecia and atrichia
12/15/2005US20050277605 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277587 CD7 as biomarker and therapeutic target for psoriasis
12/15/2005US20050277176 Human and mouse beta-defensins, antimicrobial peptides
12/15/2005US20050277175 Truncated ADAMTS molecules
12/15/2005US20050277173 inoculating human lymphocytes, mitogens or polyclonal activators, to cultures and control cultures, then determining the degree of apoptosis and proliferation in the cultures; design of synthetic immunogens; screening of ligands that yield pharmacological effects
12/15/2005US20050277172 Novel variant hypocrea jecorina CBH1cellulases
12/15/2005US20050277167 Prolyl 3-hydroxylases
12/15/2005US20050277155 Method of immobilizing probes, in particular for producing biochips
12/15/2005US20050277153 detecting the presence or absence of nucleotide sequence variants in a sample to obtained from mammals, to determine if the mammal is predisposed to cardiovscular disorders or cancer; medical diagnosis
12/15/2005US20050277152 Method for separation and purification of nucleic acid and unit for separation and purification of nucleic acid
12/15/2005US20050277151 NTR3, a novel member of the TNF- receptor supergene family
12/15/2005US20050277143 Formed by fusing a pinanediol bound to a solid support with a boronic or boric acid bound to a biomolecule; an array may be constructed by preparing the conjugate at a plurality of spatially distinct reaction sites on the solid support
12/15/2005US20050277142 Recombinant cell line for the detection of dioxin-like compounds based on the expression of luciferase gene
12/15/2005US20050277139 Methods and apparatus for the detection and validation of microRNAs
12/15/2005US20050277138 Reactive functional groups
12/15/2005US20050277136 Rapid identification of Nocardia farcinica
12/15/2005US20050277133 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy
12/15/2005US20050277132 Nematode GS-like sequences
12/15/2005US20050277126 Cytokine receptor chain
12/15/2005US20050277123 Variants of NEDD4L associated with hypertension and viral budding
12/15/2005US20050277119 Substituted azaporphyrins as fluorescence labels
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 899